Back
Immunovant Vs. Perspective Therapeutics Industry Stock Comparison
Buy
54
IMVT
Immunovant
Last Price:
29.29
Seasonality Move:
35.41%
Sell
30
CATX
Perspective Therapeutics
Last Price:
12.13
Seasonality Move:
11.55%
Buy
54
Immunovant (IMVT)
is a Buy
Is Immunovant a Buy, Sell or Hold?
- The current Immunovant [IMVT] share price is $29.17. The Score for IMVT is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- IMVT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $13.00. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
IMVT Stock Price Chart
What is Immunovant's stock price today?
-
The Immunovant share price today is $29.17
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IMVT is experiencing buying pressure, which is a positive indicator for future bullish movement.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $13.00
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing buying pressure, which is a positive indicator for future bullish movement.
IMVT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.09 | Sell |
Relative Strength Index (14 RSI): | 47.94 | Sell |
Chaikin Money Flow: | 1531714 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (28.53 - 29.83) | Sell |
Bollinger Bands (100): | (26.8 - 30.74) | Buy |
CATX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.29 | Sell |
Relative Strength Index (14 RSI): | 47.65 | Sell |
Chaikin Money Flow: | 430326 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (12.29 - 13.93) | Sell |
Bollinger Bands (100): | (11.4 - 14.56) | Buy |
IMVT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 29.57 | Sell |
20-day SMA: | 29.18 | Sell |
50-day SMA: | 29.99 | Sell |
200-day SMA: | 31.3 | Sell |
8-day EMA: | 29.39 | Sell |
20-day EMA: | 29.45 | Sell |
50-day EMA: | 29.53 | Sell |
200-day EMA: | 29.72 | Sell |
CATX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 12.9 | Buy |
20-day SMA: | 12.86 | Buy |
50-day SMA: | 13.78 | Sell |
200-day SMA: | 12.19 | Buy |
8-day EMA: | 12.84 | Buy |
20-day EMA: | 13.09 | Sell |
50-day EMA: | 13.36 | Sell |
200-day EMA: | 11.73 | Buy |
Immunovant Earnings Growth & IMVT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.16 per share, and a decrease next year of $0.66 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.38 per share, and a decrease next year of $0.04 per share.
Immunovant Technical Analysis
Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Perspective Therapeutics Technical Analysis
Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |